Companies in the on-body drug delivery devices market are
working toward launching more efficient on-body delivery systems
for injectables. They are also exploring the launch of
multifunctional system in order to send drugs where they could be
effective in the body's organs and tissues
WILMINGTON, Del., Aug. 2, 2024
/PRNewswire/ -- The on-body drug delivery devices
market is poised to expand at a CAGR of 6.8% from
2024 to 2034. By the end of the aforementioned forecast period, the
market is poised to total US$ 796.1
million in value terms. A basic advantage of an on-body
drug delivery device is that it is able to accurately target
specific cells and tissues. This minimizes the side-effects of
drugs and increase therapeutic efficacy.
An on-body drug delivery device is a patched-on device
delivering big molecules (biologics) subcutaneously and has been
designed for therapies that periodically need a specific quantity
of formulated drug. Typical applications comprise proteins such as
monoclonal antibodies (mAbs).
The advantages offered by on-body drug delivery devices include
higher level of precision at lower dosing increments, home-use with
bolus and/or basal profile, automatic needle insertion and
retraction, occlusion detection, resusable/disposable concept
supporting sustainability, and use of standard glass cartridges.
Research states that targeted drug delivery results in enhanced
pharmacokinetics such as improved absorption, distribution,
metabolism, and excretion (ADME).
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84069
Increasing preference for advanced drug delivery systems has
widened the scope for on-body drug delivery devices. Advanced drug
delivery technologies have proven to enhance treatment outcomes in
various ways, which include enhancement of therapeutic efficacy,
increasing patient compliance, reducing toxicity, and facilitating
novel medical treatments.
Key Takeaways from the Market Study
- The market for on-body drug delivery is poised to accumulate a
value of US$ 416.8 million in
2024.
- The on-body drug delivery devices market is poised for a 1.9x
growth from 2024 to 2034.
- By application, cancer is expected to emerge as an important
area for on-body drug delivery devices use.
- By product type, both wearable and auto-injectors are expected
to enjoy heightened demand throughout the forecast period.
- Hospitals are the main sites for availing on-body drug delivery
devices for patients.
Key Market Drivers and Trends
- On-body drug delivery devices help in obtaining enhanced drug
safety along with patient compliance. These devices are designed
such that therapeutic levels of drug are maintained, and
side-effects and overdose of drugs can be reduced. Besides, drugs
can be delivered with short in-vivo half-lives.
- Targeted drug delivery systems such as on-body drug delivery
devices are capable of concentrating a medicine's active ingredient
at site of a lesion/anatomical target. This keeps the drug at
effective concentration on targeted organs for a longer duration,
facilitating prescription of medicines at a lower dose.
On-body Drug Delivery Devices Market Report
Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 390.7 Mn
|
Forecast (Value) in
2034
|
US$ 796.1 Mn
|
Growth Rate
(CAGR)
|
6.8 %
|
No. of
Pages
|
136
Pages
|
Segments
covered
|
By Product Type, By
Application, By End-user
|
Unlock Growth Potential in Your Industry! Download PDF
Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84069
Regional Profile
- North America expects to
witness substantial progress with respect to on-body drug delivery
devices sales. This is attributed to growing demand for advanced
drug delivery systems such as metered-dose inhalers and
sensor-embedded devices. As per a study published by CIHI in
April 2021, more than 3 million acute
inpatient hospitalizations were witnessed in Canada from 2019 to 2020.
- The market in Europe is
expected to see substantial expansion. Europe's market growth is ascribed to rise in
awareness about advanced drug delivery devices and rise in adoption
of the advanced products.
- Various clinical trials are being conducted regularly for novel
products and introduction of new products by the key participants.
Along these lines, in April 2021,
Medtronic launched its extended infusion set in select European
nations. It can be worn for close to a week.
Competitive Landscape
Key participants in the on-body drug delivery devices market are
launching new products to strengthen their position. For instance,
in September 2023, Corium, Inc.
introduced ADLARITY, a donepezil transdermal system in the U.S. to
treat patients contracting mile-to-severe Alzheimer's.
In August 2022, Baxter announced
that it had obtained clearance from the U.S. FDA for usage of Novum
IQ Syringe Infusion Pump with Dose IQ Safety Software.
These infusion pumps deliver small quantities of fluid at
low rates in neonatal, pediatric, or anesthesia care settings with
utmost precision.
Enable Injections Inc., NOVO Engineering, Elcam Medical,
Battelle, and Gerresheimer AG are some of the key players covered
in the on-body drug delivery devices market report.
Key Players Profiled
- Enable Injections Inc.
- NOVO Engineering
- Elcam Medical
- Battelle
- Gerresheimer AG
Recent Market Developments
- In January
2024, Medtronic received CE Mark approval
for MiniMed 780G system, in collaboration with Simplera Sync.
MiniMed 780G is one of the automated insulin delivery system, which
is equipped with meal detection technology and makes provision for
automatic adjustments as well as corrections to the levels of sugar
every five minutes.
- In February 2023, Innovation
Zed received CE mark for its InsulCheck DOSE, one of the
single unit add-on device for insulin pen injectors.
Key Segments Profiled
Product Type
- Wearable Injectors
- Auto-injectors
- Patches
- Others
Application
- Cardiovascular Diseases
- Cancer
- Autoimmune Diseases
- Diabetes
- Others (Orthopedic Disorders, etc.)
End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Others (Research Institutes, etc.)
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase the Report for Market-Driven Insights:
https://www.transparencymarketresearch.com/checkout.php?rep_id=84069<ype=S
More Trending Report by Transparency Market Research:
- Mechanical Thrombectomy Devices Market - In 2022, the
Mechanical Thrombectomy Devices market was valued at USD 1.1 billion. It is projected to grow at a
CAGR of 6.4% from 2023 to 2031, reaching over USD 1.8 billion by the end of 2031.
- Sanitization Robots Market - The Sanitization Robots
market was valued at USD 927.3
million in 2022 and is anticipated to grow at a remarkable
CAGR of 19.2% from 2023 to 2031. By 2031, the market is expected to
surpass USD 4.8 billion.
- Microcatheter Market - Valued at USD 799.7 million in 2022, the Microcatheter
market is estimated to grow at a CAGR of 5.3% from 2023 to 2031.
This growth is projected to elevate the market value to
USD 1.3 billion by the end of
2031.
- Infant Resuscitators Market - The global Infant
Resuscitators market, valued at USD 253.1
million in 2022, is expected to grow at a compound annual
growth rate (CAGR) of 5.2% from 2023 to 2031. This growth is
projected to increase the market value to over USD 401.4 million by the end of 2031.
About Transparency Market Research
Transparency Market Research, a global market
research company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER
DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us:
LinkedIn| Twitter| Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/on-body-drug-delivery-devices-market-to-reach-us-796-1-million-valuation-by-2034--growing-at-6-8-cagr-tmr-report-302213339.html
SOURCE Transparency Market Research